z-logo
open-access-imgOpen Access
Radioligand therapy — personalized treatment for patients with neuroendocrine tumors
Author(s) -
Agnieszka Kolasińska-Ćwikła
Publication year - 2022
Publication title -
oncology in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 2450-6478
pISSN - 2450-1654
DOI - 10.5603/ocp.2021.0043
Subject(s) - radionuclide therapy , medicine , radioligand , neuroendocrine tumors , somatostatin receptor , peptide receptor , oncology , somatostatin , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom